The Rho-kinase (ROCK) inhibitor Y-27632 protects against excitotoxicity-induced neuronal death in vivo and in vitro

Neurotox Res. 2013 Apr;23(3):238-48. doi: 10.1007/s12640-012-9339-2. Epub 2012 Jul 19.

Abstract

Rho-associated coil kinase (ROCK) inhibitors reportedly prevent neurodegeneration, and abnormal ROCK activation in the central nervous system induces neurite collapse and retraction. However, it is unclear whether the ROCK inhibitor Y-27632 directly protects hippocampal neurons from excitotoxicity. Here, we determined the effects of Y-27632 on neuroprotection following kainic acid (KA)-induced seizures in mice and during glutamate-induced excitotoxicity in HT22 cells. One day after Y-27632 injection, mice were treated with KA and killed 1-2 days later. Fluoro-Jade B and rapid Golgi staining showed that Y-27632 protected against KA-induced neurodegeneration and neurite dystrophy. Y-27632 inhibited increases in hippocampal RhoA and ROCK2 in KA-treated mice as determined by western blot analysis. Immunohistochemical analysis revealed ROCK2-positive neurons and astrocytes in the KA-treated hippocampus. In HT22 cells, Y-27632 also protected neurons and neurite formation during glutamate-induced excitotoxicity in vitro. These results indicate that ROCK inhibition modulates neurite growth and protects neurons from excitotoxicity-induced cell death.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amides / pharmacology
  • Amides / therapeutic use*
  • Animals
  • Anticonvulsants / pharmacology
  • Anticonvulsants / therapeutic use*
  • Astrocytes / drug effects
  • Astrocytes / enzymology
  • Cell Death
  • Cells, Cultured / drug effects
  • Convulsants / antagonists & inhibitors
  • Convulsants / toxicity
  • Glial Fibrillary Acidic Protein
  • Glutamic Acid / toxicity
  • Hippocampus / cytology
  • Hippocampus / drug effects*
  • Hippocampus / enzymology
  • Hippocampus / pathology
  • Kainic Acid / toxicity
  • Male
  • Mice
  • Mice, Inbred ICR
  • Myosin Light Chains / biosynthesis
  • Myosin Light Chains / genetics
  • Nerve Tissue Proteins / antagonists & inhibitors*
  • Nerve Tissue Proteins / biosynthesis
  • Nerve Tissue Proteins / genetics
  • Neurites / drug effects
  • Neurons / drug effects*
  • Neurons / enzymology
  • Neurons / ultrastructure
  • Neurotoxins / toxicity*
  • Protein Kinase Inhibitors / pharmacology
  • Protein Kinase Inhibitors / therapeutic use*
  • Pyridines / pharmacology
  • Pyridines / therapeutic use*
  • Seizures / chemically induced
  • Seizures / prevention & control*
  • Single-Blind Method
  • rho GTP-Binding Proteins / biosynthesis
  • rho GTP-Binding Proteins / genetics
  • rho-Associated Kinases / antagonists & inhibitors*
  • rhoA GTP-Binding Protein

Substances

  • Amides
  • Anticonvulsants
  • Convulsants
  • Glial Fibrillary Acidic Protein
  • Myosin Light Chains
  • Nerve Tissue Proteins
  • Neurotoxins
  • Protein Kinase Inhibitors
  • Pyridines
  • glial fibrillary astrocytic protein, mouse
  • Y 27632
  • Glutamic Acid
  • Rock1 protein, mouse
  • Rock2 protein, mouse
  • rho-Associated Kinases
  • RhoA protein, mouse
  • rho GTP-Binding Proteins
  • rhoA GTP-Binding Protein
  • Kainic Acid